Author:
Musorina A. S.,Zenin V. V.,Turilova V. I.,Yakovleva T. K.,Poljanskaya G. G.
Reference60 articles.
1. Aghajani, F., Hooshmand, T., Khanmohammadi, M., Khanjani, S., Edalatkhah, H., Zarnani, A.H., and Kazemnejad, S., Comparative immunophenotypic characteristics, proliferative features, and osteogenic differentiation of stem cells isolated from human permanent and deciduous teeth with bone marrow, Mol. Biotechnol., 2016, vol. 58, no. 6, pp. 415–427.
2. Alessio, N., Pipino, C., Mandatori, D., Di, Tomo, P., Ferone, A., Marchiso, M., Melone, M.A.B., Peluso, G., Pandolfi, A., and Galderisi, U., Mesenchymal stromal cells from amniotic fluid are less prone to senescence compared to those obtained from bone marrow: an in vitro study, J. Cell. Physiol., 2018.
https://doi.org/10.1002/jcp.26845
3. An International System for Human Cytogenetic Nomenclature, Shaffer, I.G., Slovak, M.L., and Campbell, L.J., Eds., Basel: S. Karger, 2009.
4. Antonucci, I., Stuppia, L., Kaneko, Y., Yu, S., Tajiri, N., Bae, E.C., Chheda, S.H., Weinbren, N.L., and Borlongan, C.V., Amniotic fluid as rich source of mesenchymal stromal cells for transplantation therapy, Cell Transplant., 2011, vol. 20, pp. 789–795.
5. Barkholt, L., Flory, E., Jekerle, V., Lucas-Samuel, S., Ahnert, P., Bisset, L., Büscher, D., Fibbe, W., Foussat, A., Kwa, M., Lantz, O., Mačiulaitis, R., Palomäki, T., Schneider, C.K., Sensebé, L., Tachdjian, G., Tarte, K., Tosca, L., and Salmikangas, P., Risk of tumorigenicity in mesenchymal stromal cell-based therapies–bridging scientific observations and regulatory viewpoints, Cytotherapy, 2013, vol. 15, pp. 753–759.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献